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Abstract Saccharromyces cerevisiae CLS2 gene product 
(Cls2p) that is localized on the endoplasmic reticulum is impor- 
tant for the regulation of intracellular Ca 2+ in a compartment 
distinct from the vacuole. Using a vma3 mutation that impairs the 
Ca 2+ sequestering activity into the vacuole, we have shown that 
the cls2 mutation results in 3.4-fold increase in the Ca 2+ pool that 
is not exchangeable with extracellular Ca 2+. Accumulation of 
Ca 2÷ within the cls2 cells is synergistically elevated by the addi- 
tion of immunosuppressant, FK506. Moreover, in the vma3 back- 
ground, toxicity caused by the cls2 mutation is greatly enhanced 
by FK506. Given that FK506 inhibits the calcineurin activity, 
Cls2p likely functions in releasing Ca 2÷ flux from the endoplasmic 
reticulum, somehow cooperating with calcineurin. 
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1. Introduction 
In the budding yeast Saccharomyces cerevisiae, Ca 2÷ is essen- 
tial for cell growth [1,2]. In order to understand the cellular 
Ca 2÷ function and/or Ca 2+ homeostasis in this organism, Ohya 
et al. (1986) isolated a number of Ca2+-sensitive mutants (cls; 
calcium sensitive) that were unable to grow in the presence of 
100 mM CaC12 [3]. Based on calcium contents of whole cells and 
initial Ca R+ uptake activities, the mutants were classified into 
four types. Among 18 complementation groups of the mutants, 
type III cls mutants (clsl, cls2, and cls3 mutant) contain ele- 
vated calcium contents but exhibit normal initial rates of the 
Ca 2+ uptake. Molecular analysis of one of the type III mutants 
have shown that CLS2 encodes a hydrophobic polypeptide of 
the 410 amino acid residues [4]. The cls2 mutants were recently 
isolated by another group, and also referred to csg2 [5]. In the 
presence of high concentration f Ca 2+ (10 50 mM CaC12), the 
cls2/csg2 mutant cells accumulate a much higher amount of 
Ca 2+ presumably in a non-vacuolar compartment [5]. This is 
consistent with our observation that epitope-tagged Cls2p/ 
Csg2p is predominantly localized on the ER membrane [4]. 
Type IV els mutants, including cls7, cls8, cls9, clslO, and 
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clsll exhibit elevated initial rates of the Ca 2÷ uptake [3]. Molec- 
ular/biochemical analysis of the type IV cls mutants revealed 
that the mutations resulted in the lesion of the subunits or the 
assembly factors of the vacuolar membrane H+-ATPase, and 
were therefore renamed as vma (y_acuolar membrane ATPase) 
(cls7 = vma3, cls8 = vmal, cls9 = vmall,  clslO = vmal2 and 
clsll = vmal3) [6]. VMA3, VMA1, VMAI1 and VMA13 en- 
code the 17 kDa, 69 kDa, 17 kDa and 54 kDa subunits, respec- 
tively, and VMA12 encodes an assembly factor [6-9]. All of the 
vma mutants impair generation of the proton motive force 
across the vacuolar membrane, and are unable to sequester 
Ca 2+ into the vacuole, a major Ca 2÷ pool in yeast cells [10 17]. 
Hence, the amount of Ca 2+ in the total cellular compartments 
in cls7/vma3 cells is dramatically decreased [6,18]. 
Recent study has indicated that the vma mutants are more 
sensitive than the wild-type strain to the immunosuppressants, 
FK506 and cyclosporin A (CsA) [18]. The vma mutants do not 
grow on YPD plates containing 1/.tg/ml FK506 or 50/,tg/ml 
CsA, although the wild-type strain can grow on the same plates. 
Evidence has been accumulated in yeast and higher eukaryotic 
cells that both FK506 and CsA inhibit the activity of a Ca2+/ 
calmodulin dependent phosphoprotein phosphatase, cal- 
cineurin, and that the inhibition by the drugs depends on its 
own cytosolic receptors, FKBP-12 (Fkblp) and Cyp-18 
(Cyplp) [19 22]. We found that inhibition of the calcineurin 
activity results in increase of a non-exchangeable (compartmen- 
talized) Ca 2÷ pool, which is distinct from the vacuole, causing 
decrease of [Ca2*]o in clsT/vma3 cells [18]. This result indicates 
that calcineurin controls intracellular calcium homeostasis by 
somehow repressing Ca 2+ flux into a non-vacuolar component. 
We have noticed the coincidence that both Cls2p/Csg2p and 
calcineurin regulates a non-vacuolar compartmentalized Ca 2+ 
pool. In this study we present asynergistic relationship between 
the function of calcineurin and Cls2p/Csg2p in regulating the 
intracellular Ca 2+ homeostasis of yeast cells. 
2. Materials and methods 
2.1. Yeast strains, media and growth conditions 
YPD medium contained 1% (w/v) Bacto-yeast extract (Difco), 2% 
(w/v) Bacto-peptone, and 2% (w/v) glucose. YPD pH 5.0 medium was 
buffered with 50 mM succinate/NaOH at pH 5.0. FK506 (0.1 l gtg/ml) 
and CaC12 (1-100 raM) were supplemented in the medium when indi- 
cated in the text. The SD media for auxotroph selection were described 
in Sherman et al. [23]. 
Strains used in this study are listed in Table 1. All yeast strains used 
were derivatives ofYPH499, YPH500 or YPH501 [24], and constructed 
by transformation using the lithium acetate method or by standard 
genetic rosses. For the disruption of the CLS2 gene, pYT24 [4] was 
linearized with BamHI and used to transform haploid strains, YPH499 
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and YPH500, to construct cls2 null mutants, DCLS2-A1 and DCLS2- 
B1, respectively as described in Takita et al. [4]. 
2.2. Recombinant DNA 
All procedures for recombinant DNA were carried out with Escher- 
ichia coli strain XLl-blue (Stratagene) grown in Luria Broth medium 
with appropriate antibiotics [25]. pBluescriptII[KS+] was bought from 
Stratagene. 
2.3. Measurement of exchangeable and non-exchangeable Ca g÷ pools 
Measurement of cellular Ca 2÷ pools was described in Tanida et al. 
[18]. During this experiment, we monitored the cell viability of the vma3 
mutant and the cls2 vma3 double mutant in the presence of FK506. 
When vma3 and cls2 vma3 cells were cultured in YPD pH 5.0 medium 
containing 1/zg/ml FK506 at 30°C for 8 h, more than 95% of the cells 
was still viable. 
3. Results 
A previous report has indicated that when the cls21csg2 cells 
are exposed to high concentration of extracellular Ca 2÷ (10-50 
mM), the cells accumulate higher levels of intracellular Ca 2+ 
that is exchangeable with extracellular Ca 2+ [5]. Our study was 
undertaken in order to investigate the function of Cls2p/Csg2p 
under a normal, relatively low Ca 2+ condition (c.a. 200~tM Ca 2+ 
included in YPD pH 5.0 medium). When the wild-type cells 
were cultured in YPD pH 5.0 medium, most (91%) of the Ca 2+ 
pool was non-exchangeable with extracellular Ca 2+, largely rep- 
resenting the vacuolar Ca 2+ pool (Fig. 1). The vma3 cells, in- 
stead, contained the dramatically reduced non-exchangeable 
Ca 2+ pool (13% compared with the wild-type control), because 
the vma3 mutant impaired the Ca 2+ sequestering activity into 
the vacuole. In this strain background, the cls2lcsg2 mutation 
resulted in 3.4 fold increase in the non-exchangeable Ca2÷ pool 
(Fig. 1), suggesting that Cls2p/Csg2p regulates the non-ex- 
changeable Ca 2+ pool under the normal condition. The cls2/ 
csg2 mutation alone slightly affected the non-exchangeable 
Ca :+ pool, probably due to the fact that high CaZ+-sequestering 
activity of the vacuole decreased the difference. 
Using compounds (FK506 and cyclosporin A) that inhibit 
the calcineurin activity in yeast cells, we have shown that cal- 
cineurin regulates a non-exchangeable Ca2+ pool, which is dis- 
tinct from the vacuole [18]. In order to examine whether cal- 
cineurin regulates the same Ca 2+ pool as the one affected by the 
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Fig. 1. Ca 2÷ compartmentalization in the wild-type, cls2, vma3 and cls2 
vma3 strains. The exchangeable (open box) and non-exchangeable 
(solid box) pools of cell-associated Ca 2+ were measured in strains 
YPH499 (Wild-type), DCLS2-A1 (cls2), DV3T-A (vma3), and 
DV3DCLS2-1 (cls2 vma3) cultured in YPD pH 5.0 medium at 30°C. 
Bars indicate the variation of individual values of the total Ca 2+ pools 
from the mean (n = 2). 
cls2/csg2 mutation, we tested the sensitivity of the cls2 vma3 
cells to FK506. The theory of this experiment is that if cal- 
cineurin and Cls2p/Csg2 cooperatively regulates the same Ca 2+ 
compartments, inhibition of the calcineurin activity would 
cause synergistic effects on the cls2 vma3 cells. Here we used 
the cls2 vma3 double mutant, because phenotype of cls2/csg2 
was enhanced in the vma3 background (Fig. 1). We found that 
even a small amount of FK506 (0.1/~g/ml) inhibited the growth 
of the cls2 vma3 double mutant (Fig. 2). The control vma3 cells 
were still able to grow in the presence of the same concentration 
of FK506. Binding of FK506 to FKBP-12 (Fkblp) results in 
inhibition of calcineurin activity [19,20]. In order to confirm 
whether binding of the drug to FKBP-12 results in the growth 
inhibition in the cls2 vma3 cells, we constructed the cls2 vma3 
fkb l  triple mutant lacking FKBP-12. We found that the cls2 
Table 1 
List of yeast strains 
Strains Genotype Source 
YPH499 
YPH500 
DV3T-A 
DV3T-B 
DCLS2-A 1 
DCLS2-B 1 
DF1 
DV3CI-I IC 
DV3DCLS2-1 
DV3DCLS2-2 
DV3DCLS2DFI-I 
DV3DCLS2DF1-2 
DV3DCLS2DC 1-1 
DV3DCLS2DC 1-2 
MATa leu2 ade2 lys2 his3 trpl ura3 
MATct leu2 ade2 lys2 his3 trpl ura3 
MATa leu2 ade2 lys2 his3 trpl ura3 vma3::TRP1 
MATot leu2 ade2 lys2 his3 trpl ura3 vma3::TRP1 
MATa leu2 ade2 lys2 his3 trpl ura3 cls2::LEU2 
MATer leu2 ade2 lys2 his3 trpl ura3 cls2::LEU2 
MATct leu2 ade2 
MATa leu2 ade2 
MA Ta leu2 ade2 
MA Ta leu2 ade2 
MA Ta leu2 ade2 
MATa leu2 ade2 
MA Ta leu2 ade2 
MATa leu2 ade2 
lys2 his3 trpl ura3 fkbl:." URA3 
lys2 his3 trpl ura3 vma3.':TRP1 cTpl::NEO 
lys2 his3 trpl ura3 vms3::TRP1 cls2::LEU2 
lys2 his3 trpl ura3 vma3::TRP1 cls2.'.'LEU2 
lys2 his3 trpl ura3 vma3::TRP1 cls2::LEU2 fkbl::URA3 
lys2 his3 trpl ura3 vma3.vTRP1 cls2::LEU2 fkbl::URA3 
lys2 his3 trpl ura3 vma3::TRP1 cls2::LEU2 cypl::NEO 
lys2 his3 trpl ura3 vma3::TRP1 cls2::LEU2 cypl::NEO 
Sikorski and Hieter (1989) 
Sikorski and Hieter (1989) 
Tanida et al. (1995) 
Tanida et al. (1995) 
This study ~ 
This study" 
Tanida et al. (1995) 
Tanida et al. (1995) 
This study b
This study b
This study ¢
This study c
This study d
This study d
~This strain was constructed as described in section 2. 
bOne of the segregants from DCLS2-A1 x DV3T-B. 
cOne of the segregants from DV3DCLS2-1 × DFI. 
dOne of the segregants from DV3CI-11C x DCLS2-B1. 
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Fig. 2. FK506 causes a severe growth defect of the cls2 vma3 mutant. Yeast strains were spread onto the surface of YPD pH 5.0 agar medium (A) 
or YPD pH 5.0 agar medium with 0.1/lg/ml FK506, and incubated at 30°C for 3 days. Strains clockwise from the top were YPH499 (Wild-type), 
YPH500 (Wild-type), DV3T-A (vma3), DV3T-B (vma3), DCLS2-A1 (cls2), DCLS2-B1 (cls2), DV3DCLS2-1 (cls2 vma3), DV3DCLS2-2 (cls2 vma3), 
DV3DCLS2DFI-1 (cls2 vma3 fkbl), DV3DCLS2DF1-2 (cls2 vma3 fkbl), DV3DCLS2DCI-I (els2 vma3 cypl), DV3DCLS2DC1-2 (cls2 vma3 cypl). 
vma3 fkb l  triple mutant grew in the presence of 0.1 /,tg/ml 
FK506. The effect of CsA-Cyp-18 complex on the growth of 
the cls2 vma3 mutant was similar to the case of FK506 (data 
not shown). Together with the fact that FK506-FKBP-12 com- 
plex inhibits calcineurin activity in yeast cells, we concluded 
that inhibition of the calcineurin activity results in a severe 
growth defect of the cls2 vma3 mutant. 
Since significant increase of the non-exchangeable Ca 2÷ pool 
may account for the severe growth defect of the cls2 vma3 
mutant, we examined the effect of FK506 on cellular Ca 2÷ pools 
in the mutant cells. Fig. 3 shows that addition of 0.1 /lg/ml 
FK506 resulted in 6-fold increase of the non-exchangeable Ca 2+ 
pool of the cls2 vma3 cells: 1.0/lg/ml FK506 had more pro- 
nounced effect. FK506 had no effect on the Ca 2+ pool of the 
cls2 vma3Jkbl cells lacking FKBP-12, confirming that forma- 
tion of FK506-FKBP-12 was required for elevation of a Ca 2+ 
pool. Under these conditions, no quinacrine accumulation i to 
the vacuoles of the cls2 vma3 ceils was observed (data not 
shown), indicating that vacuolar acidification o longer oc- 
curred in the cls2 vma3 mutant. The synergistic effect on the 
non-exchangeable Ca2+ pool in the VMA cells was also ob- 
served. Addition of 1/zg/ml FK506 induced adramatic increase 
in the non-exchangeable Ca 2÷ pool of the cls2 single mutant, 
being 2.2 fold higher than that of the wild-type under the same 
condition (Fig. 3). These results suggested that both Cls2p and 
calcineurin synergistically control the non-exchangeable Ca 2+ 
pool probably in the ER. 
4. Discussion 
In the present study, we show evidence suggesting that Cls2p 
regulates the non-vacuolar compartmentalized Ca 2+ pool of the 
ER under the low Ca 2+ condition. This is consistent with the 
previous report that Ca 2+ is accumulated in the non-vacuolar 
organelle when the cells are exposed in 10-50 mM Ca 2+ [5]. 
Cls2p is a hydrophobic protein localized on the ER membrane 
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Fig. 3. The effect of FK506 on the cellular Ca 2+ pools in yeast cells. The 
exchangeable (open box) and non-exchangeable (solid box) pools of 
cell-associated Ca > were measured in strains cultured in YPD pH 5.0 
medium at 30°C without FK506 (0), with 0.1/,tg/ml (0.1) or 1/~g/ml 
FK506 (1). Strains indicated were YPH499 (Wild-type), DCLS2-A1 
(cls2), DV3T-A (vma3), DV3DCLS2-1 (c ls2 vma3), and 
DV3DCLS2DFI-I (cls2 vma3 Jkbl). Bars indicate the variation of 
individual values of the total Ca 2+ pools from the mean (n = 2). 
sideration with the synergistic growth inhibition, we propose a 
model as shown in Fig. 4. In this model, Cls2p functions in 
releasing Ca 2+ from the lumen of the ER. When the Ca 2+ efflux 
from the ER is blocked by the cls2 mutation, the Ca 2+ pool in 
the ER increased. The cls2 mutant is not able to grow in the 
presence of high concentration (100 mM) of CaCI2, probably 
due to the extraordinary high concentration of Ca 2+ in the ER. 
In this model, calcineurin also regulates the Ca > pool in the ER 
by repressing Ca 2+ influx into the lumenal space. Inhibition of 
calcineurin activity by addition of 0.1 ¢tg/ml FK506 induced 
further increase of the compartmentalized Ca2+ pool. In the 
consequence, the cls2 vma3 double mutant becomes more sen- 
sitive to immunosuppressants than the vma3 single mutant. In 
this model, however, we do not exclude the possibilty that 
calcineurin also regulates the Ca 2+ pool in the other non-vacu- 
olar compartment(s). At any rate, since calcineurin is a cy- 
tosolic protein complex, there must be a target protein of cal- 
cineurin on the ER membrane. Genetic study is now under way 
in our laboratory to identify the target protein(s) involved in 
Ca 2+ flux/homeostasis of the ER. 
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with a putative Ca 2+ binding site possibly exposed to the cyto- 
plasmic side [4,5]. Although Cls2p/Csg2p is not a homolog of 
CaZ+-ATPase or calcium channel such as the ryanodine-recep- 
tor or the IP3-receptor in mammalian cells [26-34], Cls2p/Csg2p 
likely possess an important function in Ca 2÷ homeostasis of the 
ER. 
The cls2/csg2 mutation and inhibition of calcineurin activity 
synergistically increased the intracellular non-exchangeable 
Ca 2+ pool. Even if Cls2p/Csg2p and calcineurin independently 
control the Ca2+-flux into the different organelle, the increase 
of the non-exchangeable Ca2+ pool might be additive. In con- 
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